BPA Call HHSN268201400001B-HHSN26800036

This federal contract was awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Dupage Medical Technology Inc., a minority-owned, for-profit organization, for the development of an inhibitor of integrin outside-in signaling as a new generation of anti-thrombotic drug. The definitive, cost-plus-fixed-fee contract has a ceiling value of $1,958,172.98 and a completion date of February 14, 2020. The contract was awarded on November 15, 2016 and does not have a...

The National Heart, Lung and Blood Institute (NHLBI) awarded a $90,272 firm fixed price delivery order against Betah Associates Inc.'s GSA Multiple Award Schedule contract. Betah Associates will provide conference planning services for the 2023 Sickle Cell In Focus Conference, including travel arrangements for up to 35 speakers and chairs. The NHLBI, part of the National Institutes of Health within the Department of Health and Human Services, seeks to facilitate this conference in order to...

This is a BPA call order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to ICF Incorporated, L.L.C. The order, titled "Strategic Communications & Engagement Support for Blood Diseases and Disorders," is under the NHLBI Office of Science Policy, Engagement, Education and Communications Support (OSPEEC) Blanket Purchase Agreement (BPA). The contract is a time-and-materials...

This federal contract award, with ID HHSN268201500187A, was made by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the procurement of in vitro diagnostic substances, reagents, test kits, and sets. The $388,820.00 firm fixed-price purchase order was issued to support the NHLBI Division of Intramural Research. The contract does not have a set-aside designation and was awarded on September 8,...

The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health within the Department of Health and Human Services, awarded a firm fixed price delivery order valued at $41,507.66 to Illumina, Inc. of San Diego, California. The purpose of this order is to provide reagent kits that are required by the NHLBI Sequencing Core Facility to carry out next-generation sequencing in support of Institute-funded investigators. Work will be performed in San Diego through...

Archerdx LLC, a subsidiary of Invitae Corporation, has been awarded a firm fixed price purchase order by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Under this contract, Archerdx will provide the NHLBI with custom DNA sequencing library reagents to detect and quantify the frequency of acute myeloid leukemia-associated mutations in patient samples. The contract has a period of performance from September 12, 2023 through November 11, 2023...

The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...

The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $35,041.80 firm fixed price delivery order to Illumina, Inc. to provide Illumina kits and reagents in support of next-generation sequencing activities on Illumina instruments for Institute-funded investigators. The sequencing core facility at the NHLBI requires the products from Illumina to carry out its mission of performing next-generation sequencing on Illumina...

The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (HHS-NIH-NHLBI) awarded a $156,707 purchase order to Illumina, Inc. to renew an existing Illumina service contract. The one-year firm fixed price contract will provide ongoing services in support of the NHLBI's research programs from June 2021 through June 2022. Illumina will perform the work as the prime contractor in San Diego, California. No subcontractors or set aside...

This is a $3,250,000.00 definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Trustees of Boston University (Boston University) to build and support a critical national biorepository of normal and lung disease-specific induced pluripotent stem cells (iPSCs) and their differentiated progeny. This contract supports the NHLBI's efforts to establish a sustainable resource to serve the lung research community. The...